湖北理工学院学报
湖北理工學院學報
호북리공학원학보
Journal of Huangshi Institute of Technology
2015年
1期
57-59
,共3页
柯箫韵%樊丽%金亚%朱忠梁
柯簫韻%樊麗%金亞%硃忠樑
가소운%번려%금아%주충량
糖尿病肾病%缬沙坦%葛根素
糖尿病腎病%纈沙坦%葛根素
당뇨병신병%힐사탄%갈근소
diabetes nephropathy%valsartan%puerarin
观察缬沙坦联合葛根素在早期2型糖尿病肾病治疗中的临床疗效,探讨缬沙坦联合葛根素在早期2型糖尿病肾病治疗中的作用。依据300 mg/d>微量白蛋白排泄率( UAER)≥30 mg/d,选择68例早期2型糖尿病肾病患者,并随机分为2组:观察组和对照组各34例,对照组在常规降糖治疗的基础上,加用缬沙坦胶囊80 mg/d;观察组在对照组治疗的基础上,再加用葛根素400 mg/d。疗程1个月,观察2组患者治疗前后 UAER、血清肌酐(Scr)和尿素氮(BUN)等指标。结果为:2组患者治疗后较治疗前,UAER均明显改善,治疗前后差异显著( P <0.05);而且观察组治疗后较对照组治疗后UAER下降更明显,两者存在显著性差异( P <0.05);2组患者治疗前后比较,Scr和 BUN 无统计学差异(P>0.05)。缬沙坦联合葛根素能较好地降低早期2型糖尿病肾病患者的UAER,更有效地保护肾功能。
觀察纈沙坦聯閤葛根素在早期2型糖尿病腎病治療中的臨床療效,探討纈沙坦聯閤葛根素在早期2型糖尿病腎病治療中的作用。依據300 mg/d>微量白蛋白排洩率( UAER)≥30 mg/d,選擇68例早期2型糖尿病腎病患者,併隨機分為2組:觀察組和對照組各34例,對照組在常規降糖治療的基礎上,加用纈沙坦膠囊80 mg/d;觀察組在對照組治療的基礎上,再加用葛根素400 mg/d。療程1箇月,觀察2組患者治療前後 UAER、血清肌酐(Scr)和尿素氮(BUN)等指標。結果為:2組患者治療後較治療前,UAER均明顯改善,治療前後差異顯著( P <0.05);而且觀察組治療後較對照組治療後UAER下降更明顯,兩者存在顯著性差異( P <0.05);2組患者治療前後比較,Scr和 BUN 無統計學差異(P>0.05)。纈沙坦聯閤葛根素能較好地降低早期2型糖尿病腎病患者的UAER,更有效地保護腎功能。
관찰힐사탄연합갈근소재조기2형당뇨병신병치료중적림상료효,탐토힐사탄연합갈근소재조기2형당뇨병신병치료중적작용。의거300 mg/d>미량백단백배설솔( UAER)≥30 mg/d,선택68례조기2형당뇨병신병환자,병수궤분위2조:관찰조화대조조각34례,대조조재상규강당치료적기출상,가용힐사탄효낭80 mg/d;관찰조재대조조치료적기출상,재가용갈근소400 mg/d。료정1개월,관찰2조환자치료전후 UAER、혈청기항(Scr)화뇨소담(BUN)등지표。결과위:2조환자치료후교치료전,UAER균명현개선,치료전후차이현저( P <0.05);이차관찰조치료후교대조조치료후UAER하강경명현,량자존재현저성차이( P <0.05);2조환자치료전후비교,Scr화 BUN 무통계학차이(P>0.05)。힐사탄연합갈근소능교호지강저조기2형당뇨병신병환자적UAER,경유효지보호신공능。
Objective:To observe the clinical efficacy of valsartan combined with puerarin in the treatment of early stage of type 2 diabetic nephropathy and explore effect of valsartan combined with Puerarin in the treat-ment of early stage of type 2 diabetic nephropathy .Methods: According to criteria of albumin excretion rate (UAER) >300 mg/d,68 patients with early type 2 diabetic nephropathy were randomly divided into 2 groups:observer group and control group,34 cases each group.valsartan capsule 80 mg/d were added to con-trol group on the basis of the regular hypoglycemic treatment .On the basis of the therapy of the control group , observer group was added with puerarin 400 mg/d for more than one month.UAER,erum creatinine ( Scr) and urea nitrogen ( BUN) ,and other indicators of the 2 groups were detected before and after the treatment . Results:UAER of patients in the 2 groups were significantly improved after treatment ( P<0 .05 ) ,and UAER of observation group after treatment were significantly declined (P<0.05).SCR and BUN in two groups be-fore and after treatment both showed no statistical difference ( P >0.05 ) .Conclusion:Valsartan combined with puerarin can reduce UAER in patients with early type 2 diabetic nephropathy , protect renal function more effectively .